Impact of recommendations to suspend the birth dose of hepatitis B virus vaccine

JAMA

Volumn 285, Issue 14, 2001, Pages 1874-1879

  Oram, R J ^a   Daum, R S ^a   Seal, J B ^a   Lauderdale, D S ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; THIOMERSAL;

ARTICLE; FETUS RISK; HEALTH CARE POLICY; HEALTH INSURANCE; HEPATITIS B; HOSPITAL CARE; HUMAN; MEDICAL EDUCATION; NEWBORN; NEWBORN CARE; NORMAL HUMAN; NURSERY; PRACTICE GUIDELINE; PRIORITY JOURNAL; VACCINATION; VERTICAL TRANSMISSION;

EID: 0035843619     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.285.14.1874     Document Type: Article

References (30)

1. Hepatitis B virus: A comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination: Recommendations of the Immunization Practices Advisory Committee (ACIP)
2. Universal hepatitis B immunization
3. Hepatitis B vaccination among children in inner-city housing, 1991-1997
4. Association between administration of hepatitis B vaccine at birth and completion of the hepatitis B and 4:3:1:3 vaccine series
5. Prevention of perinatal acquisition of hepatitis B virus carriage using vaccine: Preliminary report of a randomized, double-blind placebo-controlled and comparative trial
6. Notice to readers: Thimerosal in vaccines
7. Thimerosal in vaccines: An interim report to clinicians
8. Notice to readers: Availability of hepatitis B vaccine that does not contain thimerosal as a preservative
9. Recommendations regarding the use of vaccines that contain thimerosal as a preservative
10. Resume hep B immunization at birth: AAP
11. Notice to readers: Update: Expanded availability of thimerosal preservative-free hepatitis B vaccine
12. Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine
13. Comment
14. Impact of the 1999 AAP/USPHS Joint statement on thimerosal in vaccines on infant hepatitis B vaccination practices
15. Hospitals' responses to universal infant hepatitis B vaccination recommendations
16. Family physician acceptance of universal hepatitis B immunization of infants
17. Reactions of pediatricians to a new centers for disease control recommendation for universal immunization of infants with hepatitis B vaccine
18. Universal hepatitis B immunization of infants
19. Vaccine-associated liability risk and provider immunization practices
20. Regional differences in infant immunization against hepatitis B: Did intervention work?
21. Hepatitis B immunization: Premonitions and perceptions of pediatricians